- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| LUCY SCIENTIFIC DISCOVERY Aktie jetzt für 0€ handeln | |||||
| 06.09. | NSE - Lucy Scientific Discovery, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 1 | SEC Filings | ||
| 01.07. | Lucy Scientific Discovery, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 28.05. | Lucy Scientific Discovery Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c) | 155 | Business Wire | VANCOUVER, British Columbia--(BUSINESS WIRE)--Lucy Scientific Discovery Inc. (NASDAQ: LSDI), a Company dedicated to advancing the understanding and applications of psychotropic medicines, improving... ► Artikel lesen | |
| 15.03. | Pre-market Movers: Geron, Jet.AI, Zeo Energy, Cardlytics, Lucy Scientific Discovery | 626 | AFX News | SAN JOSE (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 08.00 A.M. ET).In the Green Geron Corporation (GERN) is up over 80% at $3.15.
Jet.AI... ► Artikel lesen | |
| 16.02. | Lucy Scientific Discovery Inc. Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement | 377 | Business Wire | VANCOUVER, British Columbia--(BUSINESS WIRE)--Lucy Scientific Discovery Inc. (NASDAQ: LSDI), a Company dedicated to advancing the understanding and applications of psychotropic medicines, improving... ► Artikel lesen |
5 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ASTRIA THERAPEUTICS | 9,560 | +1,16 % | Astria Therapeutics, Inc. - 8-K, Current Report | ||
| ROCKET LAB USA | 23,900 | 0,00 % | Space Technology: Rocket Lab stellt zweites Raumfahrzeug für Varda Space Industries fertig | ||
| SOLIGENIX | 2,980 | -3,25 % | SOLIGENIX, INC.: Soligenix Initiates Confirmatory Phase 3 Clinical Trial of HyBryte for the Treatment of Cutaneous T-Cell Lymphoma | FLASH2 Study opens patient enrollment PRINCETON, N.J., Dec. 16, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company... ► Artikel lesen | |
| CHARLOTTES WEB | 0,075 | -24,37 % | Charlotte's Web Holdings, Inc.: Charlotte's Web Reports 2024 Third quarter Financial Results | Sequential quarterly growth returns for 2024 New Product Innovations Driving Omni-Channel Expansion
LOUISVILLE, Colo., Nov. 14, 2024 /PRNewswire/ - (TSX: CWEB... ► Artikel lesen | |
| BOIRON | 26,600 | -0,19 % | BOIRON: EVOLUTION OF GOVERNANCE | July 3rd, 2024
The Board of Directors of Laboratoires BOIRON, meeting today under the chairmanship of Thierry BOIRON, has enacted an evolution of the Group's governance.
In this context, Thierry... ► Artikel lesen | |
| HARROW | 34,220 | -0,61 % | Harrow Health Aktie: Stabile Aussichten? | Der Aktienkurs des Augenheilkunde-Spezialisten Harrow Health verzeichnete am 07. Dezember einen bemerkenswerten Anstieg von 5,08 Prozent auf 39,32 USD. Die Entwicklung steht im Kontrast zum negativen... ► Artikel lesen | |
| AVENUE THERAPEUTICS | 1,680 | -1,75 % | Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights | MIAMI, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) ("Avenue" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of... ► Artikel lesen | |
| MEDICINOVA | 2,020 | 0,00 % | MediciNova, Inc.: MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND | LA JOLLA, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange... ► Artikel lesen | |
| ESSA PHARMA | 1,610 | +0,31 % | ESSA Pharma Inc: ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024 | Company has initiated a process to explore and review strategic options focused on maximizing shareholder value
SOUTH SAN FRANCISCO, California and VANCOUVER... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 3,650 | +0,27 % | Aquestive receives FDA Orphan Drug Exclusivity for Libervant | ||
| REVIVA PHARMACEUTICALS | 1,335 | -11,00 % | Reviva announces pricing of $18M public offering of common stock and warrants | ||
| CUMBERLAND PHARMACEUTICALS | 2,280 | -1,72 % | Cumberland Pharmaceuticals Inc.: FDA Approves Acetadote sNDA | - New Dosing Regimen Simplifies Administration -
NASHVILLE, Tenn., Dec. 9, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty... ► Artikel lesen | |
| LYRA THERAPEUTICS | 0,180 | +5,71 % | Lyra Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update | Company continues to focus on upcoming results from ENLIGHTEN 2 pivotal Phase 3 trial in CRS patients expected in 2Q 2025 Company reports topline safety results from ENLIGHTEN 1 Phase 3 extension... ► Artikel lesen | |
| SHINECO | 2,240 | +10,89 % | Shineco, Inc.: Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement | BEIJING, June 27, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a producer of innovative diagnostic medical products and related medical devices, announced today... ► Artikel lesen | |
| CYANOTECH | 0,260 | 0,00 % | CYANOTECH CORP - 8-K, Current Report |
LUCY SCIENTIFIC DISCOVERY INC gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell -23,29 % bei einem Aktienkurs von 0,514 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LUCY SCIENTIFIC DISCOVERY INC finden Sie auf Wallstreet Online.
